Cas no 1328640-39-6 (ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate)
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
- DA-12275
- ethyl 4-bromo-2-methyl-pyrazole-3-carboxylate
- AKOS015920741
- ethyl 4-bromo-2-methylpyrazole-3-carboxylate
- MBLKICOIMWDSJT-UHFFFAOYSA-N
- 1328640-39-6
- DS-9917
- Z1322794799
- MFCD20491534
- SCHEMBL16177307
- ethyl4-bromo-1-methyl-1H-pyrazole-5-carboxylate
- EN300-232695
- STL583969
- DDC64039
-
- MDL: MFCD20491534
- Inchi: 1S/C7H9BrN2O2/c1-3-12-7(11)6-5(8)4-9-10(6)2/h4H,3H2,1-2H3
- InChI Key: MBLKICOIMWDSJT-UHFFFAOYSA-N
- SMILES: BrC1C=NN(C)C=1C(=O)OCC
Computed Properties
- Exact Mass: 231.98474g/mol
- Monoisotopic Mass: 231.98474g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 3
- Complexity: 177
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 44.1?2
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Security Information
- Hazard Statement: H302-H315-H319-H335
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A049003018-1g |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 95% | 1g |
401.88 USD | 2021-05-31 | |
| Alichem | A049003018-5g |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 95% | 5g |
1,204.62 USD | 2021-05-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | E899322-5g |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | ≥95% | 5g |
4,204.80 | 2021-05-17 | |
| Chemenu | CM248863-1g |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 95% | 1g |
$204 | 2021-08-04 | |
| Chemenu | CM248863-5g |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 95% | 5g |
$561 | 2021-08-04 | |
| TRC | E901533-50mg |
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 50mg |
$ 70.00 | 2022-06-05 | ||
| TRC | E901533-100mg |
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 100mg |
$ 95.00 | 2022-06-05 | ||
| TRC | E901533-500mg |
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 500mg |
$ 340.00 | 2022-06-05 | ||
| abcr | AB455424-100 mg |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 100MG |
€176.40 | 2022-03-01 | ||
| abcr | AB455424-250 mg |
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate |
1328640-39-6 | 250MG |
€198.50 | 2022-03-01 |
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Related Literature
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
-
Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
-
M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
Additional information on ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
Introduction to Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6)
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6) is a significant compound in the field of pharmaceutical and chemical research, renowned for its versatile applications in drug synthesis and molecular biology. This compound, characterized by its unique structural framework, has garnered considerable attention due to its potential in developing novel therapeutic agents and biochemical probes.
The molecular structure of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate consists of a pyrazole core substituted with a bromine atom at the 4-position and a methyl group at the 1-position, further functionalized with a carboxylate ester group at the 5-position. This specific arrangement of functional groups makes it a valuable intermediate in organic synthesis, particularly in the construction of more complex molecules.
In recent years, the compound has been extensively studied for its role in the development of small-molecule inhibitors targeting various biological pathways. The bromine substituent, for instance, provides a reactive site for further chemical modifications, enabling the synthesis of a wide array of derivatives. These derivatives have shown promise in preclinical studies as potential candidates for treating conditions such as cancer, inflammation, and infectious diseases.
One of the most compelling aspects of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate is its utility in medicinal chemistry. Researchers have leveraged its structural features to design molecules that interact with specific enzymes and receptors involved in disease processes. For example, studies have demonstrated its efficacy in inhibiting kinases, which are critical targets in oncology research. The ability to modify the pyrazole core allows for fine-tuning of pharmacokinetic properties, enhancing drug-like characteristics such as solubility and bioavailability.
The carboxylate ester group in ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate also plays a crucial role in its applications. This moiety can be hydrolyzed to form a free carboxylic acid, which can then be further functionalized through various chemical reactions such as esterification, amidation, or coupling reactions. This flexibility makes it an indispensable building block in the synthesis of more complex pharmaceuticals.
Recent advancements in computational chemistry have further highlighted the importance of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate. Molecular modeling studies have revealed insights into how this compound interacts with biological targets at the atomic level. These insights have guided the design of more potent and selective inhibitors, paving the way for next-generation therapeutics.
The compound's significance extends beyond drug development. It has also been utilized in biochemical research as a tool for studying enzyme mechanisms and pathways. For instance, researchers have employed derivatives of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate to probe the activity of cytochrome P450 enzymes, which are involved in drug metabolism. Such studies contribute to a better understanding of how drugs are processed in the body, aiding in the optimization of drug regimens.
In conclusion, ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6) is a multifaceted compound with broad applications in pharmaceutical chemistry and biological research. Its unique structural features and reactivity make it an invaluable tool for developing new drugs and understanding complex biological processes. As research continues to uncover new applications for this compound, its importance is likely to grow even further.
1328640-39-6 (ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate) Related Products
- 175276-98-9(Methyl 4-bromo-1-ethyl-3-methyl-1H-pyrazole-5-carboxylate)
- 5775-89-3(Ethyl 4-bromo-1,3-dimethyl-1H-pyrazole-5-carboxylate)
- 400877-53-4(ethyl 4-bromo-1-methyl-pyrazole-3-carboxylate)
- 660408-08-2(Methyl 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carboxylate)
- 1185320-26-6(Methyl 4-bromo-1-ethyl-1H-pyrazole-5-carboxylate)
- 514816-42-3(Methyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate)
- 211738-66-8(methyl 4-bromo-1-methyl-pyrazole-3-carboxylate)
- 5775-88-2(4-Bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic Acid)
- 84547-84-2(4-Bromo-1-methyl-1H-pyrazole-5-carboxylic acid)
- 128537-28-0(Ethyl 4-bromo-3-ethyl-1-methyl-1H-pyrazole-5-carboxylate)